DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

11 Biopharma Reports

Irritable Bowel Syndrome

Irritable Bowel Syndrome | Current... Irritable Bowel Syndrome | Current Treatment | Detailed, Expanded Analysis - Treatment Algorithms - Claims Data Analysis - IBS Without Diarrhea (Including IBS Constipation) - (US)

January 2019

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder...

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Executive Insights | Executive Insights (US)

January 2019

MARKET OVERVIEW The irritable bowel syndrome (IBS) market has experienced...

MARKET OVERVIEW The irritable bowel syndrome (IBS) market has experienced slow growth owing to a lack of disease understanding, low rate of patients seeking treatment, and few effective......

Irritable Bowel Syndrome | Current... Irritable Bowel Syndrome | Current Treatment | Detailed, Expanded Analysis: Treatment Algorithms - Claims Data Analysis - IBS-Diarrhea (US)

December 2018

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder...

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Middle East & Africa Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Mature Markets Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Emerging Markets Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Americas Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Europe Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across forty-five countries worldwide. We report the prevalence of...

Irritable Bowel Syndrome |... Irritable Bowel Syndrome | Epidemiology | Asia Pacific Data

October 2018

DRG Epidemiology's coverage of irritable bowel syndrome comprises...

DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of irritable bow......

Irritable Bowel Syndrome | Unmet... Irritable Bowel Syndrome | Unmet Need | Detailed, Expanded Analysis (US/EU): Irritable Bowel Syndrome - Constipation Predominant

March 2018

MARKET OUTLOOK IBS-C is an indication ripe for emerging therapies; only...

MARKET OUTLOOK IBS-C is an indication ripe for emerging therapies; only three drugs have a label a......

Irritable Bowel Syndrome | Unmet... Irritable Bowel Syndrome | Unmet Need | Detailed, Expanded Analysis (US/EU): Irritable Bowel Syndrome-Diarrhea Predominant

December 2017

IBS-D is a highly prevalent disorder regularly encountered in general practice...

IBS-D is a highly prevalent disorder regularly encountered in general practice that is marked by excessive defecation and abdomi......

Connect